NSE: EMAMILTD | BSE: 531162

Mid-range Performer

Download real time

537.30 -5.05 (-0.93%)

245.7K NSE+BSE Volume

NSE 17 Dec, 2025 2:40 PM (IST)

23,453.1

Market Cap

Below industry Median

Beta 1Year

Very Low volatility

Emami Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for EMAMILTD, BSE:531162 Emami Ltd.

Search Inside the pdf :

Emami Ltd.

29 Nov 2025

537.30

-0.93%

Emami Limited Tgt 613

Buy: Emami Ltd.

BP Wealth

Emami operates primarily in beauty and healthcare, offering more than 550 products across categories such as skin care, hair care, pain management balms, cooling oils, and over-the-counter healthcare remedies. Its portfolio includes power brands like Navratna cooling oil, BoroPlus antiseptic cream, Zandu Balm, Mentho Plus, Kesh King hair oil, and Smart & Handsome (earlier Fair & Handsome) men's grooming range, many of which enjoy leadership positions in their respective niches. The company generated around Rs. 3,800+ crores in turnover in FY25, positioning it among India's larger listed FMCG companies by revenue. Emami's products are available through a wide distribution network spanning over 5.4 million retail outlets in India serviced by more than 3,400 distributors, and a global footprint in 70+ countries across SAARC, Middle East, Africa, CIS, and parts of Europe and Southeast Asia. A key pillar of Emami's strategy is continuous brand-building and innovation in ayurvedic and natural propositions that resonate strongly with Indian consumers. The...

Promoters unpledged 0.52% of shares in last quarter. Total pledge stands at 9.98% of promoter holdings

Emami Ltd.

27 Nov 2025

537.30

-0.93%

GST changes slows quarter; new product launches drive confidence for FY27

Buy: Emami Ltd.

Target

Khambatta Securities

Emami's performance in 2Q FY26 was impacted by external, non-recurring factors primarily related to the GST rate changes. Management is optimistic about a rebound in the second half of FY26.

Emami Ltd. is trading above its 50 day SMA of 531.5

Emami Ltd.

10 Nov 2025

537.30

-0.93%

Emami (HMN IN) Q2FY26 Result Update GST impact...

Accumulate: Emami Ltd.

Target

Prabhudas Lilladhar

Emami Ltd. has an average target of 656.50 from 6 brokers.

Emami Ltd.

10 Nov 2025

537.30

-0.93%

Weak delivery; recovery seems slower than anticipated

Buy: Emami Ltd.

Target

Motilal Oswal

Emami’s consolidated revenue declined 10% in 2QFY26 (inline), impacted by GST 2.0-led temporary trade disruptions in Sep’25 and extended monsoon affecting the summer portfolio.

Number of FII/FPI investors decreased from 349 to 304 in Sep 2025 qtr

Emami Ltd.

26 Aug 2025

537.30

-0.93%

Future growth initiatives mitigate muted 1Q

Buy: Emami Ltd.

Target

Khambatta Securities

Emami's performance in 1Q FY26 was impacted by external factors like
unseasonal weather which particularly affected its summer-focused portfolio.
Despite these challenges, the company's core domestic business, excluding
talc, demonstrated resilience with a 6% y-o-y revenue growth.

BP Wealth released a Buy report for Emami Ltd. with a price target of 613.0 on 29 Nov, 2025.

Emami Ltd.

07 Aug 2025

537.30

-0.93%

Muted Q1 as summer portfolio dragged performance

Buy: Emami Ltd.

Target

Sharekhan

Emami’s Q1FY26 performance beat estimates on all fronts, despite a weak summer which hit revenue growth of summer-centric portfolio.

Emami Ltd. is trading above its 50 day SMA of 531.5

Emami Ltd.

31 Jul 2025

537.30

-0.93%

Steady core performance; summer portfolio lags

Buy: Emami Ltd.

Target

Motilal Oswal

Emami reported a flat consolidated revenue in 1QFY26 (vs. an est. of -3%), as growth in the core portfolio was offset by a sharp decline in the summercentric Talc and Heat powder.

Number of FII/FPI investors decreased from 349 to 304 in Sep 2025 qtr

Emami Ltd.

16 Jun 2025, 12:00AM

537.30

-0.93%

Positive Momentum Elevates Growth Trajectory

Buy: Emami Ltd.

Target

Khambatta Securities

Emami reported healthy sales growth in 4Q FY25 despite tepid urban mass demand. In FY25, the company's domestic business launched over 25 new products.

Emami Ltd. is trading below its 100 day SMA of 559.0

Emami Ltd.

04 Jun 2025

537.30

-0.93%

Emami Ltd

Buy: Emami Ltd.

AUM Capital

Emami Ltd (Emami) is one of the leading FMCG companies that manufactures and markets personal care and healthcare products. With over 550 diverse products, the company's portfolio includes brands such as Navratna, Boroplus, Fair & Handsome,...

Number of FII/FPI investors decreased from 349 to 304 in Sep 2025 qtr

Emami Ltd.

22 May 2025

537.30

-0.93%

Steady Q4

Buy: Emami Ltd.

Target

Sharekhan

Emami’s Q4FY25 performance was steady with consolidated revenues growing by 8.1% y-o-y to Rs. 963 crore, OPM declining 89 bps y-o-y to 22.8% and adjusted PAT rising by 9.2% y-o-y to Rs. 179 crore.

BP Wealth released a Buy report for Emami Ltd. with a price target of 613.0 on 29 Nov, 2025.

Is Emami Ltd. worth buying?

233 Votes:

Buy 74.25%

Sell 17.6%

Hold 8.15%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf